Literature DB >> 1187694

Glucocorticoid-induced protection in circulatory shock: role of reticuloendotheilial system function.

B M Altura.   

Abstract

Experiments with rats indicate that: (i) hydrocortisone sodium succinate (HC) and methylprednisolone sodium succine (MP) enhance survival after hemorrhage; (ii) MP is approximately 10-times more potent than HC; (iii) both HC and MP are more efficacious if administered prior to hemorrhage; (iv) efficacy of postshock therapy with both steroids is not only time- but dose-dependent; and (v) HC and MP can ameliorate or completely prevent the early RES phagocytic depression observed in circulatory shock. Overall, these data could be used to suggest that: (i) the RES may play a pivotal role in the beneficial actions of synthetic adrenocorticosteroids in circulatory shock, and (ii) numerical RES phagocytic indices may be diagnostic and prognostic parameters in circulatory shock therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1187694     DOI: 10.3181/00379727-150-39002

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  4 in total

Review 1.  Reticuloendothelial system function and histamine release in shock and trauma: relationship to microcirculation.

Authors:  B M Altura
Journal:  Klin Wochenschr       Date:  1982-09-01

2.  Pathophysiological basis for the use of steroids in the treatment of shock and trauma.

Authors:  S Halevy; B T Altura; B M Altura
Journal:  Klin Wochenschr       Date:  1982-09-01

3.  A novel biologic immunomodulator, HDFx, protects against lethal hemorrhage, endotoxins and traumatic injury: potential relevance to emerging diseases.

Authors:  Burton M Altura; Asefa Gebrewold; Anthony Carella
Journal:  Int J Clin Exp Med       Date:  2009-09-15

4.  Testosterone: the crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage.

Authors:  D E Remmers; W G Cioffi; K I Bland; P Wang; M K Angele; I H Chaudry
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.